Order Article Reprints

Yu D, Wagner S, Schütz M, Jeon Y, Seo M, Kim J, Brückner N, Kicuntod J, Tillmanns J, Wangen C, et al. An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics. 2024; 16(2):158. https://doi.org/10.3390/pharmaceutics16020158

Yu, DongHoon, Sabrina Wagner, Martin Schütz, Yeejin Jeon, Mooyoung Seo, Jaeseung Kim, Nadine Brückner, Jintawee Kicuntod, Julia Tillmanns, Christina Wangen, and et al. 2024. "An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity" Pharmaceutics 16, no. 2: 158. https://doi.org/10.3390/pharmaceutics16020158

Yu, D., Wagner, S., Schütz, M., Jeon, Y., Seo, M., Kim, J., Brückner, N., Kicuntod, J., Tillmanns, J., Wangen, C., Hahn, F., Kaufer, B. B., Neipel, F., Eickhoff, J., Klebl, B., Nam, K., & Marschall, M. (2024). An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics, 16(2), 158. https://doi.org/10.3390/pharmaceutics16020158